Table 2 Demographic, social and clinical characteristics of CD patients and controls.
From: Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures
Demographic and social characteristics | Control group (n = 60) | Crohn’s disease (n = 61) | P | Crohn’s disease/ Active (n = 34) | Crohn’s disease/remission (n = 27) | P |
|---|---|---|---|---|---|---|
Median Age (years) | 32 | 31.5 | 0.56 | 31.1 | 34.4 | 0.11 |
White | 42 (71.2%) | 53 (88.3%) | 23 (85.2%) | 30 (90.9%) | ||
Black | 14 (23.7%) | 7 (11.7%) | 4 (14.8%) | 3 (9.1%) | ||
Other | 3 (5.1%) | 0 | 0 | 0 | ||
Relationship status | 0.02 | 0.16 | ||||
Never married | 32 (53.3%) | 26 (42.6%) | 15 (55.6%) | 11 (32.4%) | ||
Married | 16 (26.7%) | 30 (49.2%) | 11 (40.7%) | 19 (55.9%) | ||
Divorced, separated or widowed | 12 (20.0%) | 5 (8.2%) | 1 (3.7%) | 4 (11.8%) | ||
Education | 0.93 | 0.96 | ||||
High school or less | 8 (13.3%) | 7 (11.5%) | 3 (11.1%) | 4 (11.8%) | ||
Some college | 19 (31.7%) | 19 (31.2%) | 9 (33.3%) | 10 (29.4%) | ||
College degree | 23 (38.3%) | 22 (36.1%) | 10 (37%) | 12 (35.3%) | ||
Graduate degree | 10 (16.7%) | 13 (21.3%) | 5 (18.5%) | 8 (23.5%) | ||
Family income | 0.77 | 0.46 | ||||
<$20,000 | 10 (16.7%) | 7 (12.1%) | 3 (12%) | 4 (12.1%) | ||
$20,000–49,999 | 16 (27.1%) | 18 (31.0%) | 7 (28%) | 11 (33.3%) | ||
$50,000–99,999 | 23 (39.0%) | 19 (32.8%) | 6 (24%) | 13 (39.4%) | ||
$100,000–149,999 | 5 (8.5%) | 6 (10.3%) | 4 (16%) | 2 (6.1%) | ||
Chose not to answer | 5 (8.5%) | 8 (13.8%) | 5 (20%) | 3 (9.1%) | ||
Employment: Employed/in school | 49 (87.5%) | 54 (90.0%) | 0.67 | 25 (92.6%) | 29 (87.9%) | 0.68 |
Housing: Rent or Own | 52 (96.3%) | 57 (98.3%) | 0.61 | 25 (96.2%) | 32 (100%) | 0.45 |
Insured | 47 (81.0%) | 58 (95.1%) | 0.02 | 25 (92.6%) | 33 (97.1%) | 0.58 |
Current tobacco use | 2 (3.4%) | 5 (8.3%) | 0.44 | 3 (11.5%) | 2 (5.9%) | 0.64 |
BMI* (kg/m2) | 25.5 (4.6) | 25.4 (4.1) | 0.9 | 24.9 | 25.8 | 0.26 |
IBS diagnosis** | 1 (1.7%) | 14 (23.3%) | <0.01 | 7 (21.2%) | 7 (25.9%) | 0.67 |
Sleep disorder | 0 | 1 (1.6%) | 1 | 0 | 1 (3.7%) | 0.44 |
Current medications | ||||||
antiTNF*** | 0 | 42 (71.2%) | <0.01 | 23 (75%) | 18 (66.7%) | 0.48 |
Immunomodulators | 0 | 41(68.3%) | <0.01 | 21 (63.6%) | 20 (74.1%) | 0.39 |
ASA | 0 | 18 (30.5%) | <0.01 | 11 (34.4%) | 7 (25.9%) | 0.48 |
Prednisone | 0 | 3 (5.1%) | 0.25 | 3 (9.4%) | 0 | 0.24 |
Antidepressant | 4 (7.7%) | 11 (18.6%) | 0.1 | 9 (28.1%) | 2 (7.4%) | 0.05 |
